Disorders of the Colon Flashcards
Ulcerative Colitis: What is it?
Chronic inflammation of the colonic mucosa and submucosa. Inflammation is continuous, widespread, and superficial, and almost always involves the rectum.
- Hallmark finding is continuous, symmetric involvement of the colon
Ulcerative Colitis: Etiology
- Unknown
- Multifactoral (family history, genetic mutation, environmental factors, autoimmunity)
Ulcerative Colitis: Assessment Findings
- Bloody or mucus-like diarrhea, rectal bleeding, fecal incontinence
- Tenesmus (cramping pain of the anal or vesical sphincter)
- Abd pain/cramping with sense of urgency and incomplete evacuation
- Weight loss and decreased appetite
- Fever, tachycardia, anemia with toxicity (severe cases)
- Extracolonic disease features: uveitis, arthritis, dermatitis, sclerosing cholangitis
- Low energy, fatigue
- Aphthous oral mucosa ulcerations
- Clubbing of fingernails (chronic disease)
- Peripheral edema
Ulcerative Colitis: Risk Factors
Positive Family History
Ulcerative Colitis: Diagnostic Studies
- Colonoscopy or sigmoidoscopy with biopsy: establishes whether inflammation is present and defines extent of involvement
- Plan abdominal films or CT scan: identifies toxic megacolon and should be used in UC accompanied by fever, abd pain, leukocytosis
- Air contrast barium enema: often normal in early disease
- CBC to detect anemia and leukocytosis
- Sedimentation rate: elevated
- pANCA: elevated in 85% of patients
- Serum electrolytes: hypokalemia
- Stools for culture, ova and parasite, giardia, cryptosproridium, C. diff
Ulcerative Colitis: Non-Pharmacologic Management
- Complete bowel rest indicated ONLY in acute fulminant disease
- UC diet that avoids common triggers: caffeine, alcohol, carbonated beverages, lactose (patient-specific)
- Stress management
- Lifestyle modifications (exercise, healthy dietary choices)
- Surgery is curative and should be considered for disease that is unresponsive to 2-3 weeks of medical therapy
Ulcerative Colitis: Pharmacologic Management
- Oral aminosalicylates (5-ASA): treatment of choice for chronic treatment of mild to moderate disease
- 5-ASA without sulfapyridine (Mesalamine) or another first-line choice to achieve remission
- Rectal (topical) 5-ASA options only or with the oral 5-ASA as an enema or suppository
- Steroid enemas or suppositories for proctitis or proctosigmoiditis
- Oral and parenteral steroids to manage more severe exacerbations
- In patients unresponsive to steroids, immune modulators are used
- Biologic therapy when unresponsive to therapy
- Antidiarrheal should be used cautiously
Crohn’s Disease: What is it?
Chronic, slowly progressive transmural inflammation of the GI tract, small intestine (most common site), and/or large intestine, often involving the terminal ileum. Disease presentation ranges from mild to severe.
- Categorized unde the umbrella of inflammatory bowel disease (IBD)
Crohn’s Disease: Etiology
Idiopathic
Crohn’s Disease: Risk Factors
- Family history
- Cigarette smoking
- Food allergies
- Stress
Crohn’s Disease: Assessment Findings
- Diarrhea, including nocturnal
- Occasional blood in stool (subjective)
- Occult bleeding (positive occult fecal blood test or immunochemical testing)
- Hematochezia (less common than in UC)
- Fever
- Abd pain and tenderness, perianal pain
- Ulcers of the intestine or mouth
- Fatigue
- Weight loss
- Abdominal mass
- Fistulas
- Intestinal obstruction (uncommon)
- Megacolon
- Joint swelling, hepatosplenomegaly
- Bone age in children usually delayed by 2 years
Crohn’s Disease: Diagnostic Studies
- EGD: lumen narrowing with ulceration and nodularity. Cobblestone appearance, abscess and fistulas may be present
- Flexible sigmoidoscopy/colonoscopy to assess for ileocolic Crohn’s disease: polypoid mucosa changes that give a “cobblestone appearance”
- CT or MRI
- Antiglycan antibody: elevated in 75% of cases
- Barium xrays
- Sed rate: elevated
- CBC: anemia
- Albumin: below normal if severe disease
- Electrolytes: imbalances
- B12, folate deficiency
- Stool studies, fecal occult
- CRP
- Genetic testing
Crohn’s Disease: Non-Pharmacologic Treatment
- Maintain nutrition and weight
- Stress management
- Sitz baths helpful if perianal irritation present
- Drainage of perirectal abscess, if present
- Manage extracolonic manifestations
- Long-term sulfasalazine therapy is associated with reversible sterility in men
- Surgery when indicated
Crohn’s Disease: Maintaining Nutrition and Weight
- Non-pharmacologic Management
1. Avoid trigger foods
2. Low-fat diet
3. Avoid lactose (can worsen diarrhea)
4. Low-fiber diet if strictures present
5. Avoid caffeine, alcohol, nuts, seeds
6. Exercise regularly
Crohn’s Disease: When is surgery indicated?
- Abscess refractory to nonoperative management
- Intestinal obstruction
- Bowel perforation
- GI bleeding refractory to medical therapy
- Enteric fistula refractory to medical therapy
- Small bowel or colon cancer
- Persistent inflammation refractory to medical therapy
Crohn’s Disease: Pharmacologic Therapy
- Goal of therapy is to stop autoimmune response and promote healing
- Standard dose mesalamine or diazo-bonded mesalamine, sulfasalazine, or no treatment
- Oral 5-ASA for acute disease and maintenance
- For acute flare or inability to tolerate 5-ASA: antibiotics (metronidazole, ciprofloxacin)
- Short-term corticosteroids for moderate to severe disease
- Immunosuppressants such as azathioprine or mercaptopurine, methotrexate for severe, progressive disease
- Biologics such as adalimumab or inflizimab alone or in conjunction with azathioprine
- Antispasmotics, antidiarrheals, probiotics may be helpful